FAM192A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.61310001099014E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.10460000035673E-07 |
Normal-vs-Stage2 |
2.11199999999856E-05 |
Normal-vs-Stage3 |
5.08589947934013E-10 |
Normal-vs-Stage4 |
9.45649999972709E-07 |
Stage1-vs-Stage2 |
6.630000E-01 |
Stage1-vs-Stage3 |
2.136300E-02 |
Stage1-vs-Stage4 |
6.286200E-01 |
Stage2-vs-Stage3 |
3.089800E-01 |
Stage2-vs-Stage4 |
9.487400E-01 |
Stage3-vs-Stage4 |
2.115000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.42010000425685E-08 |
Normal-vs-AfricanAmerican |
1.24179999949625E-07 |
Normal-vs-Asian |
5.090200E-01 |
Caucasian-vs-AfricanAmerican |
1.757580E-01 |
Caucasian-vs-Asian |
8.232100E-02 |
AfricanAmerican-vs-Asian |
4.274400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.80528941690272E-12 |
Normal-vs-Female |
3.36729999994567E-07 |
Male-vs-Female |
1.239770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.755600E-04 |
Normal-vs-Age(41-60Yrs) |
1.98990000033206E-07 |
Normal-vs-Age(61-80Yrs) |
2.26599849995068E-11 |
Normal-vs-Age(81-100Yrs) |
2.49129999999598E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.146200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.959800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.038800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.008200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.897000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.383400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.479100E-03 |
Normal-vs-Grade 2 |
7.99809996010481E-10 |
Normal-vs-Grade 3 |
6.88059997866475E-09 |
Normal-vs-Grade 4 |
6.93689999997638E-07 |
Grade 1-vs-Grade 2 |
6.601200E-01 |
Grade 1-vs-Grade 3 |
4.842400E-01 |
Grade 1-vs-Grade 4 |
6.054600E-01 |
Grade 2-vs-Grade 3 |
5.204400E-01 |
Grade 2-vs-Grade 4 |
8.280200E-01 |
Grade 3-vs-Grade 4 |
8.105000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.46750000005336E-07 |
Normal-vs-ccB subtype |
1.04739994455372E-09 |
ccA subtype-vs-ccB subtype |
1.054410E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.01870003730443E-09 |
Normal-vs-N1 |
2.591800E-02 |
N0-vs-N1 |
6.568800E-01 |
|
|